| - SMTL ID
- 5tz3.1
- Ligands
- (3~{R})-1-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-~{N}-naphthalen-2-yl-piperidine-3-carboxamide; ZINC ION; MAGNESIUM ION
- Polypeptides
- cGMP-dependent 3',5'-cyclic phosphodiesterase
- Oligo-state
- monomer
|
| - SMTL ID
- 5tz3.2
- Ligands
- (3~{R})-1-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-~{N}-naphthalen-2-yl-piperidine-3-carboxamide; ZINC ION; MAGNESIUM ION
- Polypeptides
- cGMP-dependent 3',5'-cyclic phosphodiesterase
- Oligo-state
- monomer
|
| - SMTL ID
- 5tz3.3
- Ligands
- (3~{R})-1-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-~{N}-naphthalen-2-yl-piperidine-3-carboxamide; ZINC ION; MAGNESIUM ION
- Polypeptides
- cGMP-dependent 3',5'-cyclic phosphodiesterase
- Oligo-state
- monomer
|
| - SMTL ID
- 5tz3.4
- Ligands
- (3~{R})-1-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-~{N}-naphthalen-2-yl-piperidine-3-carboxamide; ZINC ION; MAGNESIUM ION
- Polypeptides
- cGMP-dependent 3',5'-cyclic phosphodiesterase
- Oligo-state
- monomer
|